Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
N.N. Petrov National Medical Research Center of Oncology
Alliance for Clinical Trials in Oncology
Maastricht Radiation Oncology
Medical College of Wisconsin
Medical College of Wisconsin
Samsung Medical Center